Corporate Banner
Satellite Banner
ADME Tox
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Hurel Corporation Makes New Appointment to Board

Published: Tuesday, May 21, 2013
Last Updated: Tuesday, May 21, 2013
Bookmark and Share
Leading pharmaceutical executive and toxicologist Dr. James S. MacDonald appointed to Board of Directors.

Hurel Corporation announced the appointment of James S. MacDonald, PhD, DABT to the Company’s Board of Directors.  Dr. MacDonald is the former Executive Vice President of Preclinical Development of the Schering-Plough Research Institute (“SPRI”), which was the pharmaceutical development arm of Schering Corporation prior to its acquisition by Merck & Co. in 2009.

Over a career that has spanned more than three decades, Dr. MacDonald has brought hundreds of drug candidates into development, over thirty of which have become globally registered, major drugs, including Vasotec®, Zocor®, Primaxin®, Clinoril®, Prilosec®, Fosamax®, Clarinex®, Nasonex®, Vytorin®, and Victrelis®, among others.  Dr. MacDonald joined SPRI in 1994 as Senior Vice President, Drug Safety and Metabolism, and, over the next 14 years up until the time of the Merck acquisition, he played a leading role in building one of the most distinguished and effective drug development organizations in the world.  As co-chairman of SPRI’s Early Development Committee, he directed the movement of drug candidates from discovery research into and through the development process.  Previously Dr. MacDonald held positions of increasing responsibility at Merck, including Executive Director of Toxicology.  He received his Ph.D. in toxicology in 1975 from the University of Cincinnati and completed a post-doctoral fellowship at Vanderbilt University.  He became a diplomate of the American Board of Toxicology in 1980.

“Jim MacDonald’s track record of getting pharmaceuticals approved by FDA and onto the market speaks for itself,” said Robert Freedman, Hµrel’s Chairman and CEO.  “Hµrel is privileged to benefit from Jim’s extraordinary wisdom and experience, both as a scientist and as a drug development executive.  His guidance will be invaluable.  We welcome Jim to the Board as a colleague and friend.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,100+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
The Rise of 3D Cell Culture and in vitro Model Systems for Drug Discovery and Toxicology
An overview of the current technology and the challenges and benefits over 2D cell culture models plus some of the latest advances relating to human health research.
Alzheimer’s Protein Serves as Natural Antibiotic
Alzheimer's-associated amyloid plaques may be part of natural process to trap microbes, findings suggest new therapeutic strategies.
Vitamin A May Help Improve Pancreatic Cancer Chemotherapy
The addition of high doses of a form of vitamin A could help make chemotherapy more successful in treating pancreatic cancer, according to an early study by Queen Mary University of London (QMUL).
Breakthrough Approach to Breast Cancer Treatment
Scripps scientists have designed a drug candidate that decreases growth of breast cancer cells.
Non-Toxic Approach to Treating Variety of Cancers
A team of researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine recently discovered a novel, non-toxic approach to treating a wide variety of cancers.
Making Injectable Medicine Safer
Researchers remove excess additives from drugs, which could reduce the odds of serious allergic reactions and other side effects.
An Old-New Weapon Against Emerging Chikungunya Virus
Researchers utilize existing drugs to interfere with host factors required for replication of Chikungunya virus.
Brazilian Zika Virus Strain Causes Birth Defects in Experimental Models
First direct experimental proof of causal effect, researchers say.
'Kidney on a Chip' Facilitates Safer Drug Dosing
University of Michigan researchers have used a "kidney on a chip" device to mimic the flow of medication through human kidneys and measure its effect on kidney cells.
Ketamine Metabolism Lifts Depression
NIH-funded team finds rapid-acting, non-addicting agent in mouse study.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!